| Literature DB >> 26906716 |
Guangxiang Chen1,2, Xinyu Hu1, Lei Li1, Xiaoqi Huang1, Su Lui1, Weihong Kuang3, Hua Ai4, Feng Bi5, Zhongwei Gu4, Qiyong Gong1,6.
Abstract
White matter (WM) abnormalities have long been suspected in major depressive disorder (MDD). Tract-based spatial statistics (TBSS) studies have detected abnormalities in fractional anisotropy (FA) in MDD, but the available evidence has been inconsistent. We performed a quantitative meta-analysis of TBSS studies contrasting MDD patients with healthy control subjects (HCS). A total of 17 studies with 18 datasets that included 641 MDD patients and 581 HCS were identified. Anisotropic effect size-signed differential mapping (AES-SDM) meta-analysis was performed to assess FA alterations in MDD patients compared to HCS. FA reductions were identified in the genu of the corpus callosum (CC) extending to the body of the CC and left anterior limb of the internal capsule (ALIC) in MDD patients relative to HCS. Descriptive analysis of quartiles, sensitivity analysis and subgroup analysis further confirmed these findings. Meta-regression analysis revealed that individuals with more severe MDD were significantly more likely to have FA reductions in the genu of the CC. This study provides a thorough profile of WM abnormalities in MDD and evidence that interhemispheric connections and frontal-striatal-thalamic pathways are the most convergent circuits affected in MDD.Entities:
Mesh:
Year: 2016 PMID: 26906716 PMCID: PMC4764827 DOI: 10.1038/srep21825
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram for the identification and exclusion of studies.
Summary of the 17 DTI studies (18 datasets) with TBSS included in the meta-analysis.
| Study | Subjects, n (females, n) | Age, years | Age at onset years,mean | Illness duration, years | Severity (scale type) | Diagnosis | Statistical threshold | Drug status | Diffusion directions | Quality scores (out of 12) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patients | Controls | Patients | Controls | |||||||||
| Zuo | 16 (13) | 19 (12) | 37.0 ± 9.4 | 36.6 ± 7.7 | NA | NA | 30.3 ± 6.2 (HAMD) | MDD | P < 0.005 (Uncorrected) | Medication free for >2 weeks | 25 | 11 |
| Lai | 44 (23) | 27 (15) | 36.9 ± 5.3 | 38.3 ± 11.8 | NA | 0.4 ± 0.1 | 22.1 ± 2.3 (HAMD) | First-episode MDD | P < 0.05 (FWE) | drug naive | 30 | 11 |
| Zhu | 25 (15) | 25 (15) | 20.6 ± 1.9 | 20.3 ± 1.7 | 20.2 ± 2.3 | 0.9 ± 0.7 | 35.5 ± 6.7 (CES-D) | First-episode MDD | P < 0.05 (corrected for multiple comparisons) | drug naive | 13 | 10.5 |
| Versace | 16 (12) | 24 (15) | 32.9 ± 10.0 | 27.7 ± 8.6 | 18.9 ± 7.2 | 14.7 ± 10.0 | 25.1 ± 5.5 (HAMD) | Recurrent unipolar depression | P < 0.05 (ASC) | Medication free for >2 months | NA | 11.5 |
| Choi | 134 (70) | 54 (26) | 38.5 ± 11.1 | 34.4 ± 10.1 | NA | 9.3 ± 10.4 | 19.3 ± 3.5 (HAMD) | MDD | P < 0.05 (FWE) | 98 drug naive,36 medication free | 60 | 12 |
| Murphy | 45 (29) | 45 (28) | 42.2 ± 10.8 | 36.5 ± 13.4 | NA | 14.6 ± 11.5 | 28.9 ± 6.4 (HAMD) | MDD | P < 0.05 (FWE) | 15 medication free,15 on SSRIs,15 on DASs | 61 | 12 |
| Guo | 23 (12) | 19 (9) | 27.4 ± 7.7 | 24.4 ± 4.2 | NA | 2.3 ± 3.0 | 24.5 ± 4.2 (HAMD) | Treatment-resistant depression | P < 0.01 (corrected for multiple comparisons) | Antidepressants | 13 | 10.5 |
| Han | 20 (15) | 22 (15) | 42.7 ± 12.4 | 43.7 ± 12.3 | NA | 0.37 ± 0.1 | 19.1 ± 6.7 (HAMD) | First-episode MDD | P < 0.01 (uncorrected) | drug naive | 20 | 11.5 |
| Hayashi | 30 (13) | 30 (13) | 44.0 ± 12.0 | 44.0 ± 13.0 | NA | NA | ≥14.0 (HAMD) | First-episode MDD | P < 0.05 (FWE) | drug naive | 25 | 10 |
| Kieseppa | 16 (14) | 20 (10) | 48.4 ± 10.3 | 42.0 ± 11.6 | NA | 14.1 ± NA | 26.3 ± 7.1 (BDI) | MDD | P < 0.05 (corrected for multiple comparisons) | 13 on antidepressants,1 on risperidone,4 on benzodiazepines or zopiclone | 12 | 10 |
| Lyden | 20 (12) | 28 (15) | 41.2 ± 10.3 | 39.4 ± 12.1 | 19.9 ± 11.2 | 21.6 ± 12.5 | 27.4 ± 4.5 (HAMD) | Recurrent MDD | P < 0.05 (corrected for multiple comparisons) | Medication free for >2 days | 61 | 11.5 |
| Olvet | 39 (24) | 46 (21) | 37.1 ± 11.4 | 30.3 ± 9.3 | NA | NA | 18.7 ± 4.7 (HAMD) | MDD | P < 0.05 (FWE) | Medication free for >2 weeks | 25 | 11.5 |
| Olvet | 13 (7) | 39 (21) | 33.4 ± 13.3 | 30.3 ± 9.3 | NA | NA | 19.9 ± 4.8 (HAMD) | MDD | P < 0.05 (FWE) | Medication free for >2 weeks | 25 | 11.5 |
| Seok | 86 (68) | 62 (41) | 44.7 ± 12.2 | 42.1 ± 14.5 | NA | 3.6 ± 3.8 | 14.6 ± 8.1 (HAMD) | MDD | P < 0.01 (FWE) | 45 on antidepressants,41 drug naive | 20 | 11 |
| Guo | 22 (10) | 19 (9) | 28.1 ± 9.9 | 24.4 ± 4.2 | NA | 0.2 ± 0.1 | 25.9 ± 6.3 (HAMD) | First-episode MDD | P < 0.01 (corrected for multiple comparisons) | drug naive | 13 | 10.5 |
| Korgaonkar | 29 (17) | 39 (21) | 40.5 ± 15.8 | 29.6 ± 12.7 | NA | NA | 19.1 ± 3.0 (HAMD) | MDD | P < 0.05 (FWE) | Medication free or drug naive | 42 | 10.5 |
| Wang | 41 (20) | 41 (20) | 32.4 ± 6.5 | 32.6 ± 5.3 | NA | NA | 23.8 ± 6.1 (HAMD) | First-episode MDD | P < 0.001 (Uncorrected) | drug naive | 12 | 11 |
| Xiao | 22 (12) | 22 (12) | 20.1 ± 1.6 | 20.8 ± 1.4 | NA | NA | 55.7 ± 5.8 (CES-D) | First-episode MDD | P < 0.001 (corrected for multiple comparisons) | drug naive | 13 | 11 |
Abbreviations: DTI, diffusion tensor imaging; TBSS, tract-based spatial statistics; MDD, major depressive disorder; N.A., not available; FWE, family-wise error; HAMD, Hamilton Depression Rating Scale; nMDD, depressed patients without a history of suicide attempts; sMDD, depressed patients with a history of suicide attempts; ASC, AlphaSim correction; CES-D, Center for Epidemiological Studies Depression Scale; SSRIs: selective serotonin reuptake inhibitors; DASs: dual-acting substances.
Figure 2Regional FA reductions in the genu and body of the CC as well as the left ALIC in MDD patients compared with HCS.
Significant clusters are overlaid on an MRIcron template for Windows for display purposes only. Abbreviations: FA, fractional anisotropy; CC, corpus callosum; ALIC, anterior limb of internal capsule; MDD, major depressive disorder; HCS, healthy control subjects.
Clusters of FA reductions in patients with major depressive disorder compared to healthy control subjects.
| Region | Maximum | Cluster | |||
|---|---|---|---|---|---|
| MNI coordinates x, y, z | AES-SDM value | P value | Number of voxels | Breakdown (number of voxels) | |
| Genu of CC | −6, 26, 10 | −0.112 | ∼0 | 499 | Genu of CC (307) Body of CC (182) |
| Left ALIC | −14, 4, 8 | −0.068 | 0.000098121 | 73 | Left ALIC (49) Left PLIC (17) |
Abbreviations: FA, fractional anisotropy; CC, corpus callosum; ALIC, anterior limb of internal capsule; PLIC, posterior limb of internal capsule; AES-SDM, anisotropic effect size-signed differential mapping; MNI, Montreal Neurological Institute.
Figure 3Three-dimensional images showing white matter tracts traversing two bounding boxes centred at x = −6, y = 26, z = 10 and x = −14, y = 4 and z = 8 were separately mapped with DTIquery in a single normal individual.
Left image (A) observed from the left side of the brain, right image (B) observed from above. Tracts include the interhemispheric fibres running through the genu of the CC (yellow) and the anterior thalamic radiation running through the left ALIC (green). Sagittal and axial slices mapping the FA values are shown in the background for illustrative purposes. Abbreviations: CC, corpus callosum; ALIC, anterior limb of internal capsule; FA, fractional anisotropy.
Results of the reliability and subgroup analysis of findings from the 17 DTI studies (18 datasets) with TBSS included in the meta-analysis.
| Analysis | Region of FA reduction: Genu of CC | Region of FA reduction: ALIC |
|---|---|---|
| Jackknife sensitivity analysis (discarded study) | ||
| Excluding Zuo | Yes | Yes |
| Excluding Lai | Yes | Yes |
| Excluding Zhu | Yes | Yes |
| Excluding Versace | Yes | Yes |
| Excluding Choi | Yes | Yes |
| Excluding Murphy | Yes | Yes |
| Excluding Guo | Yes | Yes |
| Excluding Han | Yes | Yes |
| Excluding Hayashi | Yes | Yes |
| Excluding Kieseppa | Yes | Yes |
| Excluding Lyden | Yes | Yes |
| Excluding Olvet | Yes | No |
| Excluding Olvet | Yes | Yes |
| Excluding Seok | Yes | Yes |
| Excluding Guo | Yes | No |
| Excluding Korgaonkar | Yes | Yes |
| Excluding Wang | Yes | Yes |
| Excluding Xiao | Yes | No |
| Descriptive analysis of quartiles | ||
| First quartile (25%) | Yes | No |
| Second quartile (median) | Yes | No |
| Third quartile (75%) | No | No |
| Subgroup analysis | ||
| Studies with first-episode, treatment-naive MDD (n = 7) | No | Yes |
| Studies with Medication free MDD (n = 14) | Yes | Yes |
“Yes” indicates that the brain region with FA reduction remained significant in the jack-knife analysis, descriptive analysis of quartiles and subgroup analysis; “No” indicates that the brain region with FA reduction was no longer significant in those analyses.
Abbreviations: DTI, diffusion tensor imaging; TBSS, tract-based spatial statistics; FA, fractional anisotropy; CC, corpus callosum; ALIC, anterior limb of internal capsule; MDD, major depressive disorder; nMDD, depressed patients without a history of suicide attempts; sMDD, depressed patients with a history of suicide attempts.
Figure 4Result of the meta-regression analysis demonstrating that the symptom severity (HAMD scores) of MDD patients is negatively correlated with FA in the genu of the CC.
In the graphs, AES-SDM values needed to create this plot were extracted from the peak of maximum slope significance, and each study is represented as a dot; the dot size reflects the sample size. The regression line (meta-regression signed differential mapping slope) is presented as a straight line. Abbreviations: FA, fractional anisotropy; CC, corpus callosum; MDD, major depressive disorder; HAMD, Hamilton Depression Rating Scale; AES-SDM, anisotropic effect size-signed differential mapping.